https://www.youtube.com/watch?v=tqq17yf768A
Drug available in China for non-small cell lung cancer (NSCLC) available from China for 10k for nine months. . The most common form of cancer. Now AstraZeneca has developed drug (zegfrovy) and charging 200K for same dosage. Only in the west!
No comments:
Post a Comment